Cubist Systematic Strategies, LLC Biotechnology

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
CDXS Codexis, Inc.	$309M	$237,000 0.0% of portfolio	77,100	Q3 2024 Reduced 43.1%
ENTA Enanta Pharmaceuticals Inc	$110M	$237,000 0.0% of portfolio	22,920	Q3 2024 Reduced 49.46%
SVRA Savara Inc	$306M	$228,000 0.0% of portfolio	53,895	Q3 2024 New
FDMT 4 D Molecular Therapeutics, Inc.	$153M	$222,000 0.0% of portfolio	20,546	Q3 2024 New
SANA Sana Biotechnology, Inc.	$641M	$194,000 0.0% of portfolio	46,653	Q3 2024 New
URGN Uro Gen Pharma Ltd.	$238M	$169,000 0.0% of portfolio	13,361	Q3 2024 Reduced 70.28%
TCRX T Scan Therapeutics, Inc.	$46.4M	$160,000 0.0% of portfolio	32,137	Q3 2024 New
AMLX Amylyx Pharmaceuticals, Inc.	$196M	$159,000 0.0% of portfolio	49,081	Q3 2024 Reduced 70.53%
NUVB Nuvation Bio Inc.	$543M	$154,000 0.0% of portfolio	67,002	Q3 2024 New
AUPH Aurinia Pharmaceuticals Inc.	$1.17B	$149,000 0.0% of portfolio	20,409	Q3 2024 New
SEER Seer, Inc.	$140M	$147,000 0.0% of portfolio	75,278	Q3 2024 Reduced 4.82%
ACET Adicet Bio, Inc.	$36.4M	$129,000 0.0% of portfolio	89,872	Q3 2024 Reduced 78.03%
MGTX Meira G Tx Holdings PLC	$278M	$121,000 0.0% of portfolio	29,189	Q3 2024 Added 20.72%
RAPT Rapt Therapeutics, Inc.	$34.4M	$111,000 0.0% of portfolio	55,520	Q3 2024 Reduced 81.2%
BLTE Belite Bio, Inc	$1.43B	$94,000 0.0% of portfolio	2,019	Q3 2024 New
TNYA Tenaya Therapeutics, Inc.	$47.2M	$94,000 0.0% of portfolio	49,094	Q3 2024 New
PRLD Prelude Therapeutics Inc	$41.1M	$83,000 0.0% of portfolio	40,102	Q3 2024 New
RPTX Repare Therapeutics Inc.	$48.2M	$72,000 0.0% of portfolio	21,175	Q3 2024 New
PDSB Pds Biotechnology Corp	$41.3M	$69,000 0.0% of portfolio	18,195	Q3 2024 Reduced 63.45%
IMUX Immunic, Inc.	$30.6M	$67,000 0.0% of portfolio	41,062	Q3 2024 New
ACIU Ac Immune Sa	$222M	$53,000 0.0% of portfolio	14,271	Q3 2024 Reduced 73.87%
VIGL Vigil Neuroscience, Inc.	$61.1M	$53,000 0.0% of portfolio	15,762	Q3 2024 Added 331.48%
CRVS Corvus Pharmaceuticals, Inc.	$231M	$52,000 0.0% of portfolio	10,026	Q3 2024 Reduced 58.85%
ETON Eton Pharmaceuticals, Inc.	$416M	$49,000 0.0% of portfolio	8,269	Q3 2024 New
OMGA Omega Therapeutics, Inc.	$21.1M	$38,000 0.0% of portfolio	31,617	Q2 2024 Added 78.18%
QSI Quantum Si Inc	$264M	$36,000 0.0% of portfolio	41,061	Q3 2024 New
MDXG Mimedx Group, Inc.	$990M	$29,000 0.0% of portfolio	4,917	Q3 2024 Reduced 93.05%
CTMX Cytom X Therapeutics, Inc.	$57.4M	$28,000 0.0% of portfolio	24,460	Q3 2024 Reduced 70.19%
PLX Protalix Bio Therapeutics, Inc.	$111M	$24,000 0.0% of portfolio	23,621	Q3 2024 Reduced 26.26%
CLSD Clearside Biomedical, Inc.	$56M	$20,000 0.0% of portfolio	16,042	Q3 2024 New
ALVR Allovir, Inc.	$926M	$16,000 0.0% of portfolio	19,997	Q3 2024 Reduced 59.86%
BCAB Bio Atla, Inc.	$17.8M	$13,000 0.0% of portfolio	7,788	Q3 2024 New
DMAC Dia Medica Therapeutics Inc.	$160M	$13,000 0.0% of portfolio	3,263	Q3 2024 New
PMVP Pmv Pharmaceuticals, Inc.	$65.2M	$12,000 0.0% of portfolio	8,648	Q3 2024 Reduced 87.62%
ALLK Allakos Inc.	$20.3M	$4,000 0.0% of portfolio	7,568	Q3 2024 Reduced 86.36%
AADI Aadi Bioscience, Inc.	$63.1M	$2,000 0.0% of portfolio	1,009	Q3 2024 Reduced 79.3%
IMRX Immuneering Corp	$50.1M	$1,000 0.0% of portfolio	660	Q3 2024 Reduced 88.72%
CTXR Citius Pharmaceuticals, Inc.	$441M	$0 0.0% of portfolio	1,301	Q3 2024 Reduced 98.9%
EYEN Eyenovia, Inc.	$2.05M	$0 0.0% of portfolio	1	Q3 2024 Reduced 99.99%
RPHM Reneo Pharmaceuticals, Inc.	$41.1M	$0 0.0% of portfolio	533	Q3 2024 Reduced 86.08%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.